Does NERATINIB Cause Malignant neoplasm progression? 47 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 47 reports of Malignant neoplasm progression have been filed in association with NERATINIB. This represents 2.3% of all adverse event reports for NERATINIB.
47
Reports of Malignant neoplasm progression with NERATINIB
2.3%
of all NERATINIB reports
4
Deaths
16
Hospitalizations
How Dangerous Is Malignant neoplasm progression From NERATINIB?
Of the 47 reports, 4 (8.5%) resulted in death, 16 (34.0%) required hospitalization.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NERATINIB. However, 47 reports have been filed with the FAERS database.
What Other Side Effects Does NERATINIB Cause?
Diarrhoea (1,193)
Nausea (527)
Fatigue (446)
Off label use (383)
Vomiting (297)
Constipation (267)
Decreased appetite (245)
Death (181)
Disease progression (142)
Weight decreased (132)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which NERATINIB Alternatives Have Lower Malignant neoplasm progression Risk?
NERATINIB vs NETARSUDIL
NERATINIB vs NETUPITANT\PALONOSETRON
NERATINIB vs NEULASTA
NERATINIB vs NEUPOGEN
NERATINIB vs NEUPRO